Clinical Trials
3 trialsNCT03939871 2020-06-23
A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02768415 2019-06-19
Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT03933982 2019-05-29
Pyrotinib
ChineseAMS
Phase 2 Unknown